TNF and psoriasis: Current evidence suggests that psoriasis is an immune-mediated disorder and novel therapies involved in the suppression of the immune responses, such as the T cell-targeted agents and tumor necrosis factor (TNF) inhibitors, have improved the outcome of the disease [9, 18].